1. Introduction {#sec1-nutrients-10-00926}
===============

Oxidative stress (OS), a pathological metabolic condition arising from imbalance between generation and clearance of active reactive oxygen species (ROS) and reactive nitrogen species (RNS), can induce significant cell damage \[[@B1-nutrients-10-00926],[@B2-nutrients-10-00926]\]. The central nervous system (CNS), with high polyunsaturated fatty acid content, high oxygen consumption, and weak antioxidative systems, is particularly vulnerable to OS, which causes neurodegenerative disorders \[[@B3-nutrients-10-00926],[@B4-nutrients-10-00926],[@B5-nutrients-10-00926]\]. Neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD) and Friedreich ataxia (FA), cause dementia, movement disorders, or motor disorders \[[@B1-nutrients-10-00926],[@B6-nutrients-10-00926],[@B7-nutrients-10-00926]\]. Several lines of evidence from the results of clinical and preclinical studies have suggested the presence of elevated levels of OS biomarkers and impairments to antioxidant defenses in the brain and peripheral tissues in neurodegenerative diseases \[[@B8-nutrients-10-00926]\]. Therefore, OS could serve as a potential treatment target, and therapeutic efforts have been aimed at reducing the ROS and strengthening the antioxidant defenses to prevent or alleviate neurodegenerative diseases.

Neural tissues are born with a panoply of antioxidant enzymes that work together with low molecular weight-free radical scavengers to reduce the cell damage caused by OS \[[@B9-nutrients-10-00926]\]. Deduced from in vitro and in vivo studies, heme oxygenases (HOs) have been recognized as dynamic sensors of cellular OS and likely arbiters of tissue redox homeostasis \[[@B9-nutrients-10-00926],[@B10-nutrients-10-00926]\]. HO-1 is exquisitely sensitive to induction by OS compared to other HO proteins. HO-1 resides within the endoplasmic reticulum (ER), where it functions in concert with NADPH cytochrome P450 reductase, to oxidize pro-oxidant heme to free ferrous iron, carbon monoxide (CO) and radical-scavenging bile pigments, such as biliverdin (BV) and bilirubin to provide cytoprotection \[[@B10-nutrients-10-00926],[@B11-nutrients-10-00926],[@B12-nutrients-10-00926]\]. Previous reports have indicated that HO-1 has neuroprotective action \[[@B13-nutrients-10-00926],[@B14-nutrients-10-00926]\]. These studies suggest that agents that induce HO-1 expression can be used to protect brain cells against oxidative and neurodegenerative conditions.

A number of phytomedicines have been proven to be effective free radical scavengers, which could reduce ROS and are beneficial for neurodegenerative diseases. Current research has explored indigenous medicines to revive cells from oxidative-mediated injury \[[@B15-nutrients-10-00926]\]. The genus *Taraxacum*, widely distributed in the warm-temperate zones of the Northern Hemisphere, belongs to the family Asteraceae, subfamily Cichorioideae, tribe Lactuceae \[[@B16-nutrients-10-00926]\]. The species *Taraxacum officinale*, commonly known as dandelion which stems from the French word "dent de lion" ("lion's tooth") \[[@B17-nutrients-10-00926]\], is an edible folk herb \[[@B18-nutrients-10-00926]\]; traditionally, it has been used in herbal medicine to treat various disorders such as hepatitis, cirrhosis, gallbladder disorders, digestive complaints, and rheumatic diseases \[[@B19-nutrients-10-00926],[@B20-nutrients-10-00926]\]. And it is reported that *Taraxacum officinale* also exhibits several biological activities, including anti-cancer, hepatoprotective effect, anti-inflammatory effects, anti-obesity effects and antidepressant effects \[[@B21-nutrients-10-00926],[@B22-nutrients-10-00926],[@B23-nutrients-10-00926],[@B24-nutrients-10-00926],[@B25-nutrients-10-00926]\]. The leaves, flowers, and roots of *T. officinale* (TO) are often eaten fresh or cooked in salads, sandwiches, and snacks and are also used to make honey, juice, coffee substitutes, wines and other drinks \[[@B26-nutrients-10-00926],[@B27-nutrients-10-00926]\]. TO crude extract is shown to possess antioxidant properties in in vitro and in vivo studies \[[@B28-nutrients-10-00926],[@B29-nutrients-10-00926],[@B30-nutrients-10-00926],[@B31-nutrients-10-00926]\]. Chi-Su Yoon et al. reported that *Taraxacum coreanum* Nakai protects against glutamate-induced neuro-cytotoxicity in HT22 cells \[[@B32-nutrients-10-00926]\]. However, there have been no studies concerning the effects of TO extract on glutamate-induced neurodegenerative disorders. In this study, we intended to investigate the neuroprotective effect of ethanol extracts of *Taraxacum officinale* Wigg. (ETOW) and the underlying mechanism by which ETOW protects against glutamate-mediated neurotoxicity.

2. Materials and Methods {#sec2-nutrients-10-00926}
========================

2.1. Chemicals {#sec2dot1-nutrients-10-00926}
--------------

Ethanol (EtOH), formic acid and methanol (MeOH) were purchased from Merck Co. (Darmstadt, Germany). Dulbecco's modified Eagle's medium (DMEM), foetal bovine serum (FBS), and other tissue culture reagents were purchased from Gibco BRL Co. (Grand Island, NY, USA). Cobalt protoporphyrin (CoPP), HO-1 inducer, and tin protoporphyrin (SnPP) were obtained from Porphyrin Products. All other chemicals were obtained from Sigma-Aldrich (St. Louis, MO, USA), unless otherwise indicated.

2.2. Preparation of Extract {#sec2dot2-nutrients-10-00926}
---------------------------

*Taraxacum officinale* Wigg. were obtained from Yili, Sinkiang, in August 2017 and were identified by Professor Huang Shan in the Qingdao University of Science & Technology. The *Taraxacum officinale* Wigg. whole plants were ground and extracted with 70% EtOH (1:20 *w*/*v*) two times under reflux for 2 h After filtration, the extracts were concentrated and evaporated to dryness and the yield is 18.6%. The extracts were stored at −20 °C until used for further experiments.

2.3. Characterization of ETOW {#sec2dot3-nutrients-10-00926}
-----------------------------

ETOW were analysed by liquid chromatography mass spectrometry-ion trap-time-of-flight (LCMS-IT-TOF) (SHIMADZU, Kyoto, Japan). Chromatography analyses of ETOW were carried out using ACQUITY UPLC HSS T3 column (2.1 × 100 mm, 1.8 μm) (Waters, Milford, MA, USA) maintained at 40 °C. The mobile phase consisted of 0.1% (*v*/*v*) formic acid solution (A) and MeOH (B). The gradient program was performed as follows: 0--20 min, 5--95% B; 20--23 min, 95% B in 23 min at a flow rate of 0.3 mL/min. Detection was done at a wavelength of 246 nm. The sample injection volume was 2 μL. Mass spectral analyses were performed with an electrospray ionization source (ESI). ESI conditions were as follows: temperature: 200 °C; nitrogen gas flow: 1.5 L/min; nebulizer pressure for positive mode 4500 V; nebulizer pressure for negative mode: −3500 V. Full mass scan spectra were recorded in positive and negative ion mode over a *m*/*z* range of 100--1000 daltons for both MS and MS/MS.

2.4. Cell Culture {#sec2dot4-nutrients-10-00926}
-----------------

Mouse hippocampal HT22 cells were obtained from Dr. Inhee Mook (Seoul National University, Gwanak-gu, Korea). HT22 cells were cultured in DMEM medium supplemented with 10% heat-inactivated FBS, streptomycin (100 mg/mL), penicillin G (100 U/mL), and [l]{.smallcaps}-glutamine (2 mM) and incubated in a humidified atmosphere containing 95% air and 5% CO~2~ at 37 °C.

2.5. Cell Viability Assays {#sec2dot5-nutrients-10-00926}
--------------------------

Cell viability was evaluated by a 3-\[4,5-Dimethylthiazol-2-yl\]-2,5-diphenyltetrazolium bromide (MTT) assay. Cells (2 × 10^4^ cells/well in 96-well plates) were incubated with MTT at a final concentration of 0.5 mg/mL for 4 h Dimethyl sulfoxide (DMSO) was added to dissolve dark blue formazan crystals formed in the viable cells. Optical density was measured at 490 nm. The optical density of formazan formed in the control (untreated) cells was considered as 100% cell viability.

2.6. Measurement of Reactive Oxygen Species Assay {#sec2dot6-nutrients-10-00926}
-------------------------------------------------

The fluorescent probe 2′,7′-dichlorofluorescein diacetate (DCF-DA) was used to measure the intracellular generation of ROS. HT22 cells (2.5 × 10^4^ cells/well in 24-well plates) were treated with 5 mM glutamate in the presence or absence of ETOW or SnPP (50 μM), an inhibitor of HO activity, and incubated for 8 h After washing with phosphate-buffered saline (PBS), the cells were stained with 10 μM DCF-DA for 30 min in the dark. The cells were further washed with PBS and extracted using 1% Triton X-100 for 10 min at 37 °C. Fluorescence was recorded at an excitation wavelength of 490 nm and emission wavelength of 525 nm using a spectrofluorometer (Spectramax Gemini XS; Molecular Devices, Sunnyvale, San Jose, CA, USA), respectively.

2.7. Preparation of Cytosolic and Nuclear Fractions {#sec2dot7-nutrients-10-00926}
---------------------------------------------------

HT22 cells were homogenized (1:20, *w*/*v*) with PER-Mammalian Protein Extraction buffer (Pierce Biotechnology, Rockford, IL, USA) containing freshly added protease inhibitor cocktail I (EMD Biosciences, San Diego, CA, USA) and 1 mM phenylmethylsulfonyl fluoride (PMSF). The cytosolic fraction of the cells was prepared by centrifugation. The cytoplasmic and nuclear extracts of HT22 cells were isolated with NE-PER nuclear and cytoplasmic extraction reagents (Pierce Biotechnology, Rockford, IL, USA) according to the manufacturer's instructions. Protein concentration was determined using a bicinchoninic acid (BCA) protein assay kit (Thermo Scientific, Rockford, IL, USA).

2.8. Western Blot {#sec2dot8-nutrients-10-00926}
-----------------

The expression of various proteins was analysed by Western blot. HT22 cells were lysed in 20 mM Tris-HCl buffer (pH 7.4) containing a protease inhibitor mixture (0.1 mM PMSF, 5 mg/mL aprotinin, 5 mg/mL pepstatin A, and 1 mg/mL chymostatin). Protein concentration was determined using a BCA protein assay kit. Thirty micrograms of protein extracts from each sample were separated with 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then electrophoretically transferred onto a Hybond-enhanced chemiluminescence (ECL) nitrocellulose membrane (Bio-Rad Laboratories, Hercules, CA, USA). The membrane was blocked with 5% non-fat dry milk and sequentially incubated with primary antibody and horseradish peroxidase (HRP)-conjugated secondary antibody (Santa Cruz Biotechnology, Dallas, TX, USA). The protein bands were visualized by ECL detection (Amersham Pharmacia Biotech, Piscataway, NJ, USA) and quantified with an image analysis program (Image Gauge v3.12 software; Fujifilm, Tokyo, Japan).

2.9. RNA Extraction and Reverse-Transcription Polymerase Chain Reaction (RT-PCR) {#sec2dot9-nutrients-10-00926}
--------------------------------------------------------------------------------

Total RNA was extracted from harvested cells using the TRIzol System (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. Total RNA was reverse-transcribed using a High Capacity RNA-to-cDNA kit (Applied Biosystems, Carlsbad, CA, USA). The cDNA was then amplified using a SYBR Premix Ex Taq kit (TaKaRa Bio Inc., Shiga, Japan) and a StepOnePlus Real-Time PCR system (Applied Biosystems). The primer sequences were as follows: HO-1, forward 5′-ACAGAAGAGGCTAAGACCGC, reverse 5′-TGTCAGGTATCTCCCTCCATT and β-actin, forward 5′-AGCCATGTACGTAGCCATCC, reverse 5′-CTCTCAGCTGTGGTGGTGAA \[[@B13-nutrients-10-00926]\]. The results were obtained in 28--30 cycles of amplification. PCR products were separated by electrophoresis, visualized under UV light, and quantified by densitometric analysis using volume integration with Quantity One (Bio-Rad Laboratories, Hercules, CA, USA).

2.10. Immunofluorescence {#sec2dot10-nutrients-10-00926}
------------------------

For localization of Nrf-2, HT22 cells were grown on Lab-Tek II chamber slides. After treatment with ETOW, cells were fixed in formalin and permeabilized with cold acetone. The cells were probed with a nuclear factor-erythroid-2-related factor 2 (Nrf2) antibody and fluorescein isothiocynate (FITC)-labelled secondary antibody (Alexa Fluor 488; Invitrogen, Carlsbad, CA, USA). To visualize the nuclei, cells were treated with 4′,6-diamino-2-phenylindole (DAPI, 1 μg/mL) for 30 min, washed with PBS for 5 min, and treated with 50 μL VectaShield (Vector Laboratories, Burlingame, CA, USA). Stained cells were visualized and photographed using a Provis AX70 fluorescence microscope (Olympus Optical, Tokyo, Japan).

2.11. Statistical Analysis {#sec2dot11-nutrients-10-00926}
--------------------------

Data are expressed as the mean ± standard deviation (SD) of at least three independent experiments. To compare three or more groups, one-way analysis of variance (ANOVA) followed by Dunnett's test was used. Statistical analysis was performed with GraphPad Prism software, version 3.03 (GraphPad Software Inc., San Diego, CA, USA).

3. Results {#sec3-nutrients-10-00926}
==========

3.1. Characterization of ETOW by LC/MS {#sec3dot1-nutrients-10-00926}
--------------------------------------

It has been reported that *Taraxacum* species have many kinds of phenolic acids and flavonoid glycosides \[[@B33-nutrients-10-00926]\]. As shown in [Table 1](#nutrients-10-00926-t001){ref-type="table"} and determined through LC/MS analysis, ETOW contain cis-Caftaric acid, trans-Coutaric acid, Ferulic acid, Esculetin, 5-*O*-Caffeoylquinic acid, Caffeic acid, Chicoric acid, Luteolin, 11β,13-dihydro-taraxinic acid, and Quercetin-3′,4′,7-trimethyl ether \[[@B33-nutrients-10-00926],[@B34-nutrients-10-00926],[@B35-nutrients-10-00926],[@B36-nutrients-10-00926]\].

3.2. Effects of ETOW on Cell Viability {#sec3dot2-nutrients-10-00926}
--------------------------------------

To determine the cytotoxic potential of ETOW, the effects on mouse hippocampal HT22 cell viability was measured using the MTT assay. ETOW (50 to 400 µg/mL) did not show significant changes to cell viability but when increased to 800 µg/mL, the cell viability slightly decreased ([Figure 1](#nutrients-10-00926-f001){ref-type="fig"}). Thus, the concentration range of ETOW was maintained between 50 and 400 µg/mL for subsequent experiments.

3.3. Effects of ETOW on Glutamate-Induced Cytotoxicity and Reactive Oxygen Species Production in HT22 Cells {#sec3dot3-nutrients-10-00926}
-----------------------------------------------------------------------------------------------------------

To evaluate the neuroprotective effects of ETOW, the cytoprotective effects and ROS scavenging activities of ETOW were examined in glutamate-induced HT22 cells. After treatment with glutamate, the viability of HT22 cells significantly decreased compared to the untreated cells ([Figure 2](#nutrients-10-00926-f002){ref-type="fig"}). Pretreatment with ETOW increased the cell viability of HT22 cell in a concentration-dependent manner ([Figure 2](#nutrients-10-00926-f002){ref-type="fig"}A). Glutamate markedly increased intracellular ROS generation in HT22 cells. After pretreatment with ETOW, the generation of ROS induced by glutamate was downregulated significantly ([Figure 2](#nutrients-10-00926-f002){ref-type="fig"}B). Trolox (50 μM), used as a positive control for its antioxidative effects, showed a significantly cytoprotective effect and ROS scavenging activity. The results demonstrated that ETOW attenuated glutamate-induced cytotoxicity and ROS generation in HT22 cells.

3.4. Effects of ETOW on Expression of HO-1 in HT22 Cells {#sec3dot4-nutrients-10-00926}
--------------------------------------------------------

To determine the effect of ETOW on HO-1, the expression of HO-1 at both protein and mRNA levels was investigated following by ETOW treatment. ETOW increased the expression of HO-1 at both protein and mRNA levels in a concentration-dependent manner ([Figure 3](#nutrients-10-00926-f003){ref-type="fig"}A,B). The HO-1 inducer CoPP, used as a positive control, significantly increased HO-1 expression at both protein and mRNA levels ([Figure 3](#nutrients-10-00926-f003){ref-type="fig"}A,B). Treatment with ETOW (400 µg/mL) increased the protein and mRNA levels of HO-1 in a time-dependent manner within 18 h, and levels slightly decreased thereafter ([Figure 3](#nutrients-10-00926-f003){ref-type="fig"}C,D). The results showed that ETOW promoted HO-1 expression.

3.5. Effects of ETOW on Nrf2 Translocation in HT22 Cells {#sec3dot5-nutrients-10-00926}
--------------------------------------------------------

Because Nrf2 is a key upstream modulator HO-1 induction \[[@B37-nutrients-10-00926]\], the Nrf2 translocation was investigated. After incubation with ETOW (400 µg/mL), the expression of Nrf2 in nuclear fractions was increased in a time-independent manner ([Figure 4](#nutrients-10-00926-f004){ref-type="fig"}A). In contrast, the expression of Nrf2 in cytosolic fractions declined accordingly ([Figure 4](#nutrients-10-00926-f004){ref-type="fig"}B). Similar results were observed using immunofluorescence microscopy ([Figure 4](#nutrients-10-00926-f004){ref-type="fig"}C). The results indicated that ETOW induced Nrf2 translocation.

3.6. Effects of ETOW-Induced HO-1 Expression Pathway in Glutamate-Induced HT22 Cells {#sec3dot6-nutrients-10-00926}
------------------------------------------------------------------------------------

To investigate the role of HO-1 in the neuroprotective effects of ETOW, the HO-1 pathway was inhibited by SnPP. ETOW significantly suppressed glutamate-induced cytotoxicity ([Figure 5](#nutrients-10-00926-f005){ref-type="fig"}A) and ROS generation ([Figure 5](#nutrients-10-00926-f005){ref-type="fig"}B). SnPP treatment effectively reversed the inhibitory action of ETOW on glutamate-induced cytotoxicity and reactive oxygen species generation ([Figure 5](#nutrients-10-00926-f005){ref-type="fig"}A,B). Therefore, it could be deduced that ETOW inhibited glutamate-induced cytotoxicity and ROS generation in part by inducing the HO-1 expression pathway.

4. Discussion {#sec4-nutrients-10-00926}
=============

Neurodegenerative diseases, a heterogeneous group of disorders characterized by gradually progressive, selective loss of anatomically or physiologically related neuronal systems, would result in the worsening of neurological dysfunction and are ultimately fatal \[[@B1-nutrients-10-00926],[@B7-nutrients-10-00926],[@B38-nutrients-10-00926]\]. It is necessary to diagnose timely and to conduct the appropriate therapeutic intervention to stop the progression of disease and suffering of patients. Traditional Chinese medicine has potential in the treatment of neurodegenerative diseases for its multi-target, multi-link, multi-way characteristics. For example, *Ginkgo biloba* \[[@B39-nutrients-10-00926]\], *Panax ginseng* \[[@B40-nutrients-10-00926]\], and *Astragalus* \[[@B41-nutrients-10-00926]\] have shown neuroprotective effects. In this work, we studied the neuroprotective activity of ETOW in glutamate-stimulated HT22 cells.

Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system \[[@B42-nutrients-10-00926]\]. However, an excessive concentration of glutamic acid leads to death of neurons \[[@B43-nutrients-10-00926]\]. Neuron damage can be triggered by glutamate in two ways: One is glutamate receptor-mediated oxidative excitotoxicity caused by the excessive influx of Ca^2+^ and modification of calcium homeostasis; the other is ROS-linked oxidative damage which is mainly linked to the glutamate/cysteine anti-porter requiring delivery of cysteine \[[@B15-nutrients-10-00926]\]. The HT22 cells, an immortalized neuronal cell line derived from the mouse hippocampus, lack functional ionotropic glutamate receptors \[[@B44-nutrients-10-00926]\]. Therefore, the HT22 cells are frequently used for studying the non-receptor-mediated oxidative glutamate toxicity mechanism, namely, in the glutamate-induced OS in vitro model which excludes excitotoxicity as a cause for glutamate-stimulated neuronal death \[[@B45-nutrients-10-00926]\]. In our present study, we investigated the neuroprotective effects of *Taraxacum officinale* Wigg. in glutamate-induced HT22 cells. We found that non-toxic concentrations of ETOW were able to attenuate glutamate-induced cytotoxicity and ROS generation ([Figure 2](#nutrients-10-00926-f002){ref-type="fig"}A,B), suggesting that ETOW could act as a potential neuroprotective agent.

HO-1, a 32 kDa member of the stress protein superfamily, is also known as heat shock protein (Hsp)-32. HO-1 and its enzymatic products including CO, BV and bilirubin, play important roles in regulating the biological oxidative stress system \[[@B14-nutrients-10-00926]\]. There is ample evidence implicating a neuroprotective role for HO-1 both in vitro and in vivo \[[@B10-nutrients-10-00926]\]. The nuclear transcriptional factor, Nrf2, which belongs to the Cap 'N' Collar (CNC) family that contains a conserved basic leucine zipper (bZIP) transcription factor, plays an important role in HO-1 expression \[[@B46-nutrients-10-00926]\]. The Nrf2-medicated pathway is known as an essential protective mechanism against OS \[[@B47-nutrients-10-00926]\]. Under physiological conditions, Nrf2 remains in the cytoplasm bound to Kelch-like ECH associated protein 1 (Keap1), an Nrf2 inhibitor that acts as a sensor for ROS/electrophilic stress, and Bach1, a bZip transcription factor, forms heterodimers with musculoaponeurotic fibrosarcoma oncogene homologue K (MafK); under stressful conditions, Nrf2 releases from Keap1 and translocates to the nucleus where it heterodimerizes with a small Maf protein, binds to antioxidant response element (ARE), and finally activates HO-1 gene transcription \[[@B46-nutrients-10-00926],[@B48-nutrients-10-00926],[@B49-nutrients-10-00926],[@B50-nutrients-10-00926]\]. In our investigation, we found that ETOW induced HO-1 protein expression and increased the levels of Nrf2 in the nucleus ([Figure 3](#nutrients-10-00926-f003){ref-type="fig"} and [Figure 4](#nutrients-10-00926-f004){ref-type="fig"}). In addition, experiments with SnPP indicated that the expression of HO-1 evoked by ETOW was positively associated with neuroprotective effects in HT22 cells ([Figure 5](#nutrients-10-00926-f005){ref-type="fig"}). These results indicated that ETOW might exert neuroprotective effects by activating Nrf2/HO-1.

Taken together, our study demonstrated that ETOW attenuated glutamate-induced OS in HT22 cells, which is related to activation of Nrf2/HO-1 (by promoting Nrf2 translocation to the nucleus and HO-1 expression). Therefore, *Taraxacum officinale* Wigg. may have the potential to be used for neuroprotective agents through suitable exploitation and uptake.
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![Effects of ETOW on cell viability in HT22 cells. HT22 cells were incubated for 12 h with various concentrations (50, 100, 200, 400, 800 μg/mL) of ETOW. Cell viability was determined by MTT. Each bar represents the mean ± SD (*n* = 3). ETOW, ethanol extracts of *Taraxacum officinale* Wigg.](nutrients-10-00926-g001){#nutrients-10-00926-f001}

![Effects of ETOW on glutamate-induced oxidative neurotoxicity and reactive oxygen species production in glutamate-induced HT22 cells. HT22 cells were pretreated with various concentrations (50, 100, 200, 400 µg/mL) of ETOW (**A**,**B**) and then incubated for 12 h with glutamate (5 mM). Trolox (50 μM) was used as a positive control. Cell viability (**A**) and ROS (**B**) production were measured by MTT assay and DCF fluorescence measurement, respectively. Values are calculated as percentages of untreated cells. Each bar represents the mean ± SD (*n* = 3). \* *p* \< 0.05 compared to the group treated with 5 mM glutamate. The "+"and "−" signs indicates the presence or absence.](nutrients-10-00926-g002){#nutrients-10-00926-f002}

![Effects of ETOW on HO-1 protein and mRNA expression in HT22 cells. HT22 cells were incubated for 12 h with various concentrations (50, 100, 200, 400 µg/mL) of ETOW (**A**,**B**). HT22 cells were incubated with 400 µg/mL of ETOW for various periods (**C**,**D**). CoPP (20 μM) was used as a positive control. The expression of HO-1 protein (A,C) and mRNA (B,D) were assessed by Western blot and RT-PCR, respectively. Protein and gene expression results for HO-1 were normalized to actin. Each bar represents the mean ± SD (*n* = 3). \* *p* \< 0.05 compared to the control group. The "+"and "−" signs indicates the presence or absence.](nutrients-10-00926-g003){#nutrients-10-00926-f003}

![Effects of ETOW on Nrf2 translocation in HT22 cells. HT22 cells were incubated with 400 µg/mL of ETOW for 0.5, 1, or 1.5 h. The cytosolic and nuclear extracts were fractionated using PER-Mammalian Protein Extraction buffer. Nrf2 protein expression was detected by Western blot in cytosolic and nuclear extracts (**A**,**B**). Nrf2 translocation was detected by immunofluorescence (**C**). The levels of cytosolic and nuclear Nrf2 were normalized to the β-actin and lamin B, respectively. \* *p* \< 0.05.](nutrients-10-00926-g004){#nutrients-10-00926-f004}

![Effects of ETOW-induced HO-1 on glutamate-induced cytotoxicity and reactive oxygen species generation in HT22 cells. HT22 cells were pretreated with 400 µg/mL ETOW in the presence or absence of 50 μM SnPP and then exposed to glutamate (5 mM) for 12 h Cell viability (**A**) and ROS (**B**) production were measured by the MTT assay and DCF fluorescence measurement, respectively. Each bar represents the mean ± SD (*n* = 3). \* *p* \< 0.05. The "+"and "−" signs indicates the presence or absence.](nutrients-10-00926-g005){#nutrients-10-00926-f005}

nutrients-10-00926-t001_Table 1

###### 

Composition of ETOW.

  -------------------------------------------------------------------------------------------------------------------------------------
  Tentative Identification            M     t~R~ (min)   *m*/*z* Traces(−)   *m*/*z* Traces(+)   MS^2^
  ----------------------------------- ----- ------------ ------------------- ------------------- --------------------------------------
  cis-Caftaric acid                   312   2.4--2.6     311.0283            335.0603            MS^2^(−)\[311.0285\]:\
                                                                                                 149.0075, 179,\
                                                                                                 135.0441

  trans-Coutaric acid                 296   3.7--3.8     295.0349                                MS^2^(−)\[295.0354\]:\
                                                                                                 163.0370,119.0506,\
                                                                                                 113, 164

  Ferulic acid                        194   4.26--4.3                        217.1082            MS^2^(+)\[217.1082\]:\
                                                                                                 217.1086,\
                                                                                                 144.0847

  Esculetin                           178   4.45--4.50   177.0147                                

  5-*O*-Caffeoylquinic acid           354   4.55--4.57   353.0755                                MS^2^(−)\[353.0750\]:\
                                                                                                 191.051, 354.077,\
                                                                                                 179

  Caffeic acid                        180   4.6          179.0313                                MS^2^(−)\[179.0323\]: 135

  Chicoric acid                       474   6.4--6.49    473.0541                                MS^2^(−)\[473.0563\]: 311.029, 293,\
                                                                                                 179.033, 474.059,\
                                                                                                 149, 312,\
                                                                                                 294, 219.0252,\
                                                                                                 341.0544

  Luteolin                            286   10.3--10.4   285.0308            287.0739            

  11β,13-dihydro-taraxinic acid       264   10.7         263.1202                                MS^2^(−)\[263.1202\]:\
                                                                                                 219.1327, 245.1085

  Quercetin-3',4',7-trimethyl ether   344   18.5--18.6                       345                 MS^2^(+)\[345.2637\]:\
                                                                                                 345.2638
  -------------------------------------------------------------------------------------------------------------------------------------

ETOW, ethanol extracts of *Taraxacum officinale* Wigg.
